Treatment with a soluble receptor for activin improves bone mass and structure in the axial and appendicular skeleton of female cynomolgus macaques (Macaca fascicularis)-Reference-Cited by-同舟云学术

Treatment with a soluble receptor for activin improves bone mass and structure in the axial and appendicular skeleton of female cynomolgus macaques (Macaca fascicularis)

Published:2010-01 Issue:1 Volume:46 Page:64-71
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Fajardo Roberto José,Manoharan Rajaram K.,Pearsall R. Scott,Davies Monique V.,Marvell Tod,Monnell Travis E.,Ucran Jeffrey A.,Pearsall Amelia E.,Khanzode Deepali,Kumar Ravindra,Underwood Kathryn W.,Roberts Benjamin,Seehra Jasbir,Bouxsein Mary L.

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference33 articles.

1. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis;Black;N. Eng. J. Med.,2003

2. Inhibitory effects of activin-A on osteoblast differentiation during cultures of fetal rat calvarial cells;Ikenoue;J. Cell. Biochem.,1999

3. The activin A-follistatin system: potent regulator of human extracellular matrix mineralization;Eijken;FASEB J.,2007

4. Activin A is an essential cofactor for osteoclast induction;Fuller;Biochem. Biophys. Res. Commun.,2000

5. Activin enhances osteoclast-like cell formation in vitro;Sakai;Biochem. Biophys. Res. Commun.,1993

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting activins and inhibins to treat reproductive disorders and cancer cachexia;Journal of Endocrinology;2023-04-20

2. Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study;Metabolism;2023-04

3. Functionally diverse heteromeric traps for ligands of the transforming growth factor-β superfamily;Scientific Reports;2021-09-15

4. Myelo-deception: Luspatercept & TGF-Beta ligand traps in myeloid diseases & anemia;Leukemia Research;2020-10

5. Development of two complementary LC–HRMS methods for analyzing sotatercept in dried blood spots for doping controls;Bioanalysis;2019-05